Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms

•IDCH differs from LCH in its clinical, molecular, and immunohistochemical features.•IDCH is often associated with other hematopoietic neoplasms, and such cases are associated with an inferior prognosis. [Display omitted] Indeterminate dendritic cell histiocytosis (IDCH) is a rare and poorly underst...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood advances 2024-11, Vol.8 (22), p.5796-5805
Hauptverfasser: Ozkaya, Neval, Melloul Benizri, Sarah, Venkataraman, Girish, Karai, Laszlo J., Fraitag, Sylvie, Razanamahery, Jérôme, Pittaluga, Stefania, Battistella, Maxime, Pack, Svetlana, Le Pelletier, François, Xi, Liqiang, Moreau, Anne, Lee, Ina, Hélias-Rodzewicz, Zofia, Donadieu, Jean, Haroche, Julien, Raffeld, Mark, Jaffe, Elaine S., Emile, Jean-François
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•IDCH differs from LCH in its clinical, molecular, and immunohistochemical features.•IDCH is often associated with other hematopoietic neoplasms, and such cases are associated with an inferior prognosis. [Display omitted] Indeterminate dendritic cell histiocytosis (IDCH) is a rare and poorly understood entity characterized by accumulation of CD1a+/S100+ histiocytes (as Langerhans cell histiocytosis [LCH]) but with reduced-absent expression of Langerin/CD207. We assembled 43 cases of IDCH (defined by CD1a+/CD207
ISSN:2473-9529
2473-9537
2473-9537
DOI:10.1182/bloodadvances.2024013545